Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Pre-Tax Income : ¥630 Mil (TTM As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Shenzhenlubris Pharmaceuticals Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Shenzhenlubris Pharmaceuticals Co's pretax income for the three months ended in Mar. 2024 was ¥231 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ¥630 Mil. Shenzhenlubris Pharmaceuticals Co's pretax margin was 21.15%.

During the past 13 years, Shenzhenlubris Pharmaceuticals Co's highest Pretax Margin was 43.05%. The lowest was 2.07%. And the median was 28.59%.

Shenzhenlubris Pharmaceuticals Co Pre-Tax Income Historical Data

The historical data trend for Shenzhenlubris Pharmaceuticals Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhenlubris Pharmaceuticals Co Pre-Tax Income Chart

Shenzhenlubris Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

851.35

56.74

599.84

713.73

641.76

Shenzhenlubris Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															242.04	149.52	158.41	91.80	230.74

Competitive Comparison of Shenzhenlubris Pharmaceuticals Co's Pre-Tax Income

For the Medical Instruments & Supplies subindustry, Shenzhenlubris Pharmaceuticals Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shenzhenlubris Pharmaceuticals Co's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhenlubris Pharmaceuticals Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Shenzhenlubris Pharmaceuticals Co's Pre-Tax Income falls into.

Shenzhenlubris Pharmaceuticals Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Shenzhenlubris Pharmaceuticals Co's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	643.256	+	0	+	-17.373	+	68.644	+	-52.766
	=	642

Shenzhenlubris Pharmaceuticals Co's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	224.142	+	0	+	-3.951	+	-15.215	+	25.759
	=	231

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥630 Mil.

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Pre-Tax Income Explanation

Shenzhenlubris Pharmaceuticals Co's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	230.735	/	1090.969
	=	21.15%

During the past 13 years, Shenzhenlubris Pharmaceuticals Co's highest Pretax Margin was 43.05%. The lowest was 2.07%. And the median was 28.59%.

Shenzhenlubris Pharmaceuticals Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Shenzhenlubris Pharmaceuticals Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

1901 Chuangzhan Center, 6007 Shennan Road, Futian District, Shenzhen, CHN

Website

https://www.salubris.com

Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, innovative biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other global countries and regions.

Executives

Yan Jie	Directors, executives
Yang Jian Feng	Secretary, Director
Zhao Song Ping	Executives
Liu Jun	Executives
Li Ai Zhen	Supervisors
Chen Ping	Executives
Ye Cheng Hai	Director
Lu Feng	Executives, directors
Chen Qiong Xing	Supervisors
Li Ying Hui	Supervisors
Pan Ling Man	Independent director
Zhang Zhong Xing	Executives

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Headlines

No Headlines